Alon Ben-Noon (@noonalon) 's Twitter Profile
Alon Ben-Noon

@noonalon

Leading NeuroSense Therapeutics (Nasdaq: $NRSN), a Clinical stage Biotech company, accelerating therapies for ALS and Neurodegenerative diseases.

ID: 1213345396023390208

linkhttps://www.neurosense-tx.com/ calendar_today04-01-2020 06:24:32

284 Tweet

1,1K Followers

2,2K Following

Alon Ben-Noon (@noonalon) 's Twitter Profile Photo
Alon Ben-Noon
@noonalon

6 months ago

Exciting progress in the fight against ALS! ๐ŸŽ‰ $NRSN 12-month PARADIGM study data shows promising regulation of iron levels, correlating with significant improvements in ALS survival and disease mitigation. Positive biomarker data alongside clinical efficacy brings us one step